Phosphate-binding magnesium salts and uses thereof
AssigneeCypress Pharmaceutical, Inc.
InventorsRobert L. Lewis, Charles E. Day
Life of this patent
Estimating the term…
Abstract
The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.
Claims30
A composition suitable for treating hyperphosphatemia comprising a therapeutically effective dose of at least one calcium salt and at least one phosphate-binding magnesium salt.
3-6. (canceled)
10-16. (canceled)
(canceled)
(canceled)
(canceled)
A composition suitable for treating hyperphosphatemia comprising a therapeutically effective dose of at least one phosphate-binding magnesium salt, wherein the at least one phosphate-binding magnesium salt binds at least about 50 mg phosphate per gram.
(canceled)
A composition suitable for treating hyperphosphatemia comprising a therapeutically effective dose of at least one phosphate-binding magnesium salt, wherein the at least one phosphate-binding magnesium salt is not magnesium carbonate.
29-40. (canceled)
A composition suitable for treating hyperphosphatemia consisting essentially of a calcium salt and a phosphate-binding magnesium salt.
42-63. (canceled)
A method of treating hyperphosphatemia comprising administering to a subject in need of treatment a calcium salt and a phosphate-binding magnesium salt.
68-91. (canceled)
A method of treating hyperphosphatemia comprising administering to a subject in need of treatment a phosphate-binding magnesium salt, wherein the phosphate-binding magnesium salt binds at least about 50 mg phosphate per gram.
A method of treating hyperphosphatemia comprising administering to a subject in need of treatment a phosphate-binding magnesium salt, wherein the phosphate-binding magnesium salt is not magnesium carbonate.
94-106. (canceled)
Dependencies are inferred from the claim text.